EXPEDITION MEDICINES Trademark

Trademark Overview


On Tuesday, March 4, 2025, a trademark application was filed for EXPEDITION MEDICINES with the United States Patent and Trademark Office. The USPTO has given the EXPEDITION MEDICINES trademark a serial number of 99067174. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Friday, May 22, 2026. This trademark is owned by Expedition Medicines, Inc.. The EXPEDITION MEDICINES trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals for the treatment, prevention, mitigation, management, or diagnosis of viral, bacterial, fungal, parasitic, prion based, metabolic, endocrine, cardiovascular, cardiopulmonary, sexual dysfunction, hepatological, ophthalmic, neurological, hormonal, psychiatric, genetic, rare, hematological, musculoskeletal, renal, nutritional, otolaryngological, pediatric, developmental, and pain-related diseases and disorders; therapeutics, namely, therapeutic agents for the treatment, prevention, mitigation, management, or diagnosis of viral, bacterial, fungal, parasitic, prion based, metabolic, endocrine, cardiovascular, cardiopulmonary, sexual dysfunction, hepatological, ophthalmic, neurological, hormonal, psychiatric, genetic, rare, hematological, musculoskeletal, renal, nutritional, otolaryngological, pediatric, developmental, and pain-related diseases and disorders; protein-based and small molecule therapeutics, namely, therapeutic agents for the treatment, prevention, mitigation, ...

Downloadable software for use in the pharmaceuticals and healthcare fields, namely, for enabling and facilitating molecular research, research and development of pharmaceutical products and chemical compounds, design of chemical structures, and analysis of biological or chemical activity; downloadable software for providing life science analytics

Scientific research, namely, research and analysis services for the design and characterization of biologic therapeutic products; research services in the fields of genomic and transcriptomic analysis; genomic analysis and sequencing services for scientific and research purposes; medical and scientific research in the fields of genetics, genomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; research, development, and consultancy in the field of genomics; consultancy in the field of proteomics; medical research, namely, compiling data for research purposes in the field of genomics; Software as a service (SAAS) services featuring software using artificial intelligence for use in the fields of healthcare for enabling and facilitating molecular research, research and development of pharmaceutical products and chemical compounds, design of chemical structures, and analysis of biological or chemical activity; software as a service (SAAS)...

General Information


Serial Number99067174
Word MarkEXPEDITION MEDICINES
Filing DateTuesday, March 4, 2025
Status731 - SECOND EXTENSION - GRANTED
Status DateFriday, May 22, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 16, 2025

Trademark Statements


Goods and ServicesPharmaceuticals for the treatment, prevention, mitigation, management, or diagnosis of viral, bacterial, fungal, parasitic, prion based, metabolic, endocrine, cardiovascular, cardiopulmonary, sexual dysfunction, hepatological, ophthalmic, neurological, hormonal, psychiatric, genetic, rare, hematological, musculoskeletal, renal, nutritional, otolaryngological, pediatric, developmental, and pain-related diseases and disorders; therapeutics, namely, therapeutic agents for the treatment, prevention, mitigation, management, or diagnosis of viral, bacterial, fungal, parasitic, prion based, metabolic, endocrine, cardiovascular, cardiopulmonary, sexual dysfunction, hepatological, ophthalmic, neurological, hormonal, psychiatric, genetic, rare, hematological, musculoskeletal, renal, nutritional, otolaryngological, pediatric, developmental, and pain-related diseases and disorders; protein-based and small molecule therapeutics, namely, therapeutic agents for the treatment, prevention, mitigation, management, or diagnosis of viral, bacterial, fungal, parasitic, prion-based, metabolic, endocrine, cardiovascular, cardiopulmonary, sexual dysfunction, hepatological, ophthalmic, neurological, hormonal, psychiatric, genetic, rare, hematological, musculoskeletal, renal, nutritional, otolaryngological, pediatric, developmental, and pain-related diseases and disorders; protein based and small molecule pharmaceuticals for the treatment, prevention, mitigation, management, or diagnosis of viral, bacterial, fungal, parasitic, prion-based, metabolic, endocrine, cardiovascular, cardiopulmonary, sexual dysfunction, hepatological, ophthalmic, neurological, hormonal, psychiatric, genetic, rare, hematological, musculoskeletal, renal, nutritional, otolaryngological, pediatric, developmental, and pain-related diseases and disorders; pharmaceuticals for the diagnosis of cancer, genitourinary, oncological, respiratory, gastrointestinal, dermatological, immune system-related, autoimmune, rheumatological, and age-related diseases and disorders; therapeutics, namely, therapeutic agents for the diagnosis of cancer, genitourinary, oncological, respiratory, gastrointestinal, dermatological, immune system-related, autoimmune, rheumatological, and age-related diseases and disorders; protein-based and small molecule therapeutics, namely, therapeutic agents for the diagnosis of cancer, genitourinary, oncological, respiratory, gastrointestinal, dermatological, immune system-related, autoimmune, rheumatological, and age-related diseases and disorders; protein-based and small molecule pharmaceuticals for the diagnosis of cancer, genitourinary, oncological, respiratory, gastrointestinal, dermatological, immune system-related, autoimmune, rheumatological, and age-related diseases and disorders; protein-based therapeutics, namely, therapeutic agents for the treatment, prevention, mitigation, or management of cancer, genitourinary, oncological, respiratory, gastrointestinal, dermatological, immune system-related, autoimmune, rheumatological, and age-related diseases and disorders; protein-based pharmaceuticals for the treatment, prevention, mitigation, or management of cancer, genitourinary, oncological, respiratory, gastrointestinal, dermatological, immune system-related, autoimmune, rheumatological, and age-related diseases and disorders
NOT AVAILABLE"MEDICINES"
Goods and ServicesDownloadable software for use in the pharmaceuticals and healthcare fields, namely, for enabling and facilitating molecular research, research and development of pharmaceutical products and chemical compounds, design of chemical structures, and analysis of biological or chemical activity; downloadable software for providing life science analytics
Goods and ServicesScientific research, namely, research and analysis services for the design and characterization of biologic therapeutic products; research services in the fields of genomic and transcriptomic analysis; genomic analysis and sequencing services for scientific and research purposes; medical and scientific research in the fields of genetics, genomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; research, development, and consultancy in the field of genomics; consultancy in the field of proteomics; medical research, namely, compiling data for research purposes in the field of genomics; Software as a service (SAAS) services featuring software using artificial intelligence for use in the fields of healthcare for enabling and facilitating molecular research, research and development of pharmaceutical products and chemical compounds, design of chemical structures, and analysis of biological or chemical activity; software as a service (SAAS) services featuring software using artificial intelligence for use in the biotechnology field for discovering and designing biomolecules and chemical structures; software as a service (SAAS) services featuring software using artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical and genomic research; providing temporary use of on-line non downloadable software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; DNA analysis and sequencing services for scientific and research purposes; providing on-line non downloadable software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta genomics, meta-transcriptomics, and microbiomics; platform as a service (PaaS) featuring computer software platforms for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; software as a service (SAAS) services featuring software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, and meta-transcriptomics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 4, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateTuesday, August 19, 2025
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 4, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameExpedition Medicines, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
US

Party NameExpedition Medicines, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
US

Trademark Events


Event DateEvent Description
Tuesday, March 4, 2025NEW APPLICATION ENTERED
Tuesday, March 4, 2025APPLICATION FILING RECEIPT MAILED
Thursday, July 24, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 6, 2025ASSIGNED TO EXAMINER
Friday, August 8, 2025NON-FINAL ACTION WRITTEN
Friday, August 8, 2025NON-FINAL ACTION E-MAILED
Friday, August 8, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 19, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 19, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 19, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 20, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 10, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 16, 2025PUBLISHED FOR OPPOSITION
Tuesday, September 16, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 11, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, December 11, 2025SOU TEAS EXTENSION RECEIVED
Thursday, December 11, 2025SOU EXTENSION 1 FILED
Thursday, December 11, 2025SOU EXTENSION 1 GRANTED
Friday, December 12, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, May 2, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 11, 2025TEAS REQUEST TO DIVIDE RECEIVED
Thursday, December 11, 2025DIVISIONAL REQUEST RECEIVED
Friday, May 22, 2026DIVISIONAL PROCESSING COMPLETE
Wednesday, December 10, 2025SOU EXTENSION 2 FILED
Friday, May 22, 2026SOU EXTENSION 2 GRANTED
Friday, May 22, 2026CORRECTED NOA E-MAILED
Saturday, May 23, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED